TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Acquired by

Dec 18, 2024 · Barclays PLC increased its position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 83.9% in the third quarter, according to the company in its …

9%
OFF

TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Acquired By

2 weeks from now

Dec 18, 2024 · Barclays PLC increased its position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 83.9% in the third quarter, according to the company in its …

marketbeat.com

0%
OFF

TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Bought By

2 weeks from now

4 days ago · JPMorgan Chase & Co. lifted its stake in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 60.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 720,798 …

marketbeat.com

$36.84
OFF

Tg Therapeutics Stock Price Today (NASDAQ: TGTX) Quote, …

2 weeks from now

Jan 6, 2025 · TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Acquired by Russell Investments Group Ltd. ... (NASDAQ: TGTX) Tg Therapeutics's 52-week high was $36.84, and its 52-week …

wallstreetzen.com

91%
OFF

TG Therapeutics Inc, TGTX:NAQ Summary - FT.com - Financial Times

2 weeks from now

Jan 8, 2025 · Latest TG Therapeutics Inc (TGTX:NAQ) share price with interactive charts, historical prices, comparative ... TG Therapeutics Inc (TGTX:NAQ) closed at 28.77, -21.91% …

ft.com

$2
OFF

TG Therapeutics: Subcutaneous Briumvi Data A Key Near-Term …

2 weeks from now

1 day ago · When I last wrote about TG Therapeutics (NASDAQ:TGTX) in March 2024, I rated the company a buy, ... The company bought back 92,301 shares for $2.1M in Q3'24. As of …

seekingalpha.com

$4.12
OFF

TG Therapeutics Inc Stock , TGTX - Markets Insider

2 weeks from now

4 days ago · TG Therapeutics Inc's market capitalization is $4.12 B by 155.66 M shares outstanding. Is TG Therapeutics stock a Buy, Sell or Hold? TG Therapeutics stock has …

businessinsider.com

27%
OFF

TG Therapeutics (Nasdaq:TGTX) - Simply Wall St

2 weeks from now

Jan 8, 2025 · Optimistic Investors Push TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Up 27% But Growth Is Lacking Nov 07. TG Therapeutics: Modest Q3 Sales Beat, Focus Shifts To Early …

simplywall.st

1%
OFF

Have Insiders Been Selling TG Therapeutics, Inc. (NASDAQ:TGTX) …

2 weeks from now

Aug 4, 2021 · TG Therapeutics insiders own about US$269m worth of shares (which is 8.1% of the company). This kind of significant ownership by insiders does generally increase the …

nasdaq.com

8%
OFF

TG Therapeutics Stock Rises On Strong Q4 And Full-year Revenue

2 weeks from now

1 day ago · Investing.com -- TG Therapeutics, Inc. (NASDAQ: NASDAQ:TGTX) shares climbed 8% after the company reported preliminary net product revenue for the fourth quarter and full …

investing.com

9%
OFF

TG Therapeutics (NASDAQ:TGTX) Shares Gap Up - Time To Buy?

2 weeks from now

23 hours ago · NBC Securities Inc. boosted its holdings in TG Therapeutics by 58.9% in the 3rd quarter. NBC Securities Inc. now owns 1,309 shares of the biopharmaceutical company's …

marketbeat.com

$103
OFF

TG Therapeutics Reports Preliminary BRIUMVI Revenue Of $103.6 …

2 weeks from now

TG Therapeutics announced preliminary BRIUMVI revenues of $103.6 million in Q4 2024 and $310 million for the full year. Quiver AI Summary. TG Therapeutics, Inc. reported preliminary …

nasdaq.com

5%
OFF

TG Therapeutics (TGTX) Moves 7.5% Higher: Will This Strength Last?

2 weeks from now

15 hours ago · TG Therapeutics (TGTX Quick Quote TGTX - Free Report) shares ended the last trading session 7.5% higher at $29.74. The jump came on an impressive volume with a higher …

zacks.com

$525
OFF

TG Therapeutics Stock Gains On Briumvi Sales (TGTX:NASDAQ)

2 weeks from now

1 day ago · According to TG Therapeutics (NASDAQ:TGTX), the intravenously delivered treatment is expected to generate about $525M in net product revenue this year from the U.S., …

seekingalpha.com

9%
OFF

TG Therapeutics (NASDAQ:TGTX) Given "Buy" Rating At HC …

2 weeks from now

15 hours ago · NBC Securities Inc. grew its holdings in shares of TG Therapeutics by 58.9% during the third quarter. NBC Securities Inc. now owns 1,309 shares of the biopharmaceutical …

marketbeat.com

$50
OFF

TG Therapeutics, Inc. Provides Revenue Guidance For Fourth …

2 weeks from now

7 hours ago · TG Therapeutics, Inc. provided revenue guidance for fourth quarter, full year of 2024, and full year 2025. ... TD Cowen Initiates TG Therapeutics at Buy With $50 Price Target …

marketscreener.com

FAQs about TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Acquired by Coupon?

Who owns TG Therapeutics Inc?

Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC. TGTX | Complete TG Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ...

Where can I buy shares of TG Therapeutics?

Shares of TGTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of TG Therapeutics own? ...

Is TG Therapeutics stock a good buy?

TG Therapeutics stock has received a consensus rating of buy. The average rating score is and is based on 19 buy ratings, 5 hold ratings, and 3 sell ratings. What was the 52-week low for TG Therapeutics stock? The low in the last 52 weeks of TG Therapeutics stock was 11.26. ...

Will TG Therapeutics (tgtx) make you rich in 2025?

In this article, we are going to take a look at where TG Therapeutics, Inc. (NASDAQ:TGTX) stands against the other stocks that will make you rich in 2025. Jurrien Timmer, Director of Global Macro at Fidelity Management & Research Company, recently shared his outlook for the stock market in 2025. ...

How were TG Therapeutics' earnings last quarter?

TG Therapeutics, Inc. (NASDAQ:TGTX) announced its quarterly earnings data on Monday, November, 4th. The biopharmaceutical company reported $0.02 EPS for the quarter, missing analysts' consensus estimates of $0.03 by $0.01. The business's quarterly revenue was down 49.4% on a year-over-year basis. ...

What was the closing price of TG Therapeutics Inc share?

Discover the best brokers for stock trading and ordering other assets! On Monday 11/18/2024 the closing price of the TG Therapeutics Inc share was $29.63 on BTT. Compared to the opening price on Monday 11/18/2024 on BTT of $29.62, this is a gain of 0.02%. ...